ADAG Competitors & Alternatives
Compare Adagene Inc with similar stocks in the same industry
Biotechnology
ADAG
Main Stock$4.02
Tradestie Score
42
Market Cap
$94.26M
Revenue Growth
73.3%
Analyst Upside
+167.2%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.34
|
$297.23M | - | 47 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$37.63
|
$293.03M | - | 30 | Compare |
|
OMER
Omeros Corporation
|
$19.27
|
$281.75M | 11.2 | 35 | Compare |
|
DBVT
DBV Technologies S.A.
|
$14.55
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.09
|
$275.13M | - | 46 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$23.36
|
$269.08M | 0.1 | 48 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.85
|
$262.67M | - | 48 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.42
|
$258.18M | - | 41 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$38.63
|
$256.54M | - | 41 | Compare |
More ADAG Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry